Abstract European Journal of Cardio-thoracic Surgery 31 (2007) 714—718 Operative complications and early mortality after induction therapy for lung cancer§ Federico Venuta *, Marco Anile, Daniele Diso, Mohsen Ibrahim, Tiziano De Giacomo, Matilde Rolla, Valeria Liparulo, Giorgio F. Coloni Cattedra di Chirurgia Toracica, Policlinico Umberto I, Universita` di Roma ‘‘La Sapienza’’, V.le del Policlinico, 00100 Rome, Italy Received 28 September 2006; received in revised form 20 December 2006; accepted 15 January 2007 Objective: Induction therapy for advanced lung cancer allows improvement of completeness of resection and survival. However, predictive risk factors for postoperative complications and early mortality remain controversial. We report our 14-year experience with this combined approach. Methods: One hundred and thirty-nine patients (100 males and 39 females) underwent induction therapy and surgery for stage IIIA and B lung cancer. The mean age was 58.4 7.7 years. We retrospectively collected demographic data, preoperative functional parameters, type of operation, associated disorders, staging, induction regimen (chemotherapy alone or associated with radiotherapy). Univariate and multivariate analyses were performed to identify predictors of postoperative complications and early mortality. Results: One hundred and nine patients received chemotherapy (mainly based on cisplatin and gemcitabine) and 30 received chemoradiotherapy (median dose 50 Gy). Complications developed in 49 patients (35%). The most frequent was persistent air leakage (23—30% of the lobectomies), followed by cardiac complications, respiratory failure, and infections. Five patients (3.5%) died in the postoperative period and four of them had received pneumonectomy (mortality for pneumonectomy: 12.5%). The statistical analysis demonstrated that only pneumonectomy was associated with an increased mortality risk with no differences between intra- and extrapericardial dissection or right and left pneumonectomy. Conclusions: Induction therapy seems to be associated with an increased incidence of air leakage; the risk of other complications is acceptable. Pneumonectomy is associated with an increased risk of mortality and should be performed in selected patients. # 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Operative complications and early mortality after induction therapy for lung cancer / Venuta, Federico; Anile, Marco; Diso, Daniele; Ibrahim, Mohsen; DE GIACOMO, Tiziano; Rolla, M; Liparulo, V; Coloni, Giorgio Furio. - In: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. - ISSN 1010-7940. - STAMPA. - 31:4(2007), pp. 714-718. [10.1016/j.ejcts.2007.01.017]

Operative complications and early mortality after induction therapy for lung cancer

VENUTA, Federico;ANILE, MARCO;DISO, DANIELE;IBRAHIM, MOHSEN;DE GIACOMO, Tiziano;COLONI, Giorgio Furio
2007

Abstract

Abstract European Journal of Cardio-thoracic Surgery 31 (2007) 714—718 Operative complications and early mortality after induction therapy for lung cancer§ Federico Venuta *, Marco Anile, Daniele Diso, Mohsen Ibrahim, Tiziano De Giacomo, Matilde Rolla, Valeria Liparulo, Giorgio F. Coloni Cattedra di Chirurgia Toracica, Policlinico Umberto I, Universita` di Roma ‘‘La Sapienza’’, V.le del Policlinico, 00100 Rome, Italy Received 28 September 2006; received in revised form 20 December 2006; accepted 15 January 2007 Objective: Induction therapy for advanced lung cancer allows improvement of completeness of resection and survival. However, predictive risk factors for postoperative complications and early mortality remain controversial. We report our 14-year experience with this combined approach. Methods: One hundred and thirty-nine patients (100 males and 39 females) underwent induction therapy and surgery for stage IIIA and B lung cancer. The mean age was 58.4 7.7 years. We retrospectively collected demographic data, preoperative functional parameters, type of operation, associated disorders, staging, induction regimen (chemotherapy alone or associated with radiotherapy). Univariate and multivariate analyses were performed to identify predictors of postoperative complications and early mortality. Results: One hundred and nine patients received chemotherapy (mainly based on cisplatin and gemcitabine) and 30 received chemoradiotherapy (median dose 50 Gy). Complications developed in 49 patients (35%). The most frequent was persistent air leakage (23—30% of the lobectomies), followed by cardiac complications, respiratory failure, and infections. Five patients (3.5%) died in the postoperative period and four of them had received pneumonectomy (mortality for pneumonectomy: 12.5%). The statistical analysis demonstrated that only pneumonectomy was associated with an increased mortality risk with no differences between intra- and extrapericardial dissection or right and left pneumonectomy. Conclusions: Induction therapy seems to be associated with an increased incidence of air leakage; the risk of other complications is acceptable. Pneumonectomy is associated with an increased risk of mortality and should be performed in selected patients. # 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
2007
01 Pubblicazione su rivista::01a Articolo in rivista
Operative complications and early mortality after induction therapy for lung cancer / Venuta, Federico; Anile, Marco; Diso, Daniele; Ibrahim, Mohsen; DE GIACOMO, Tiziano; Rolla, M; Liparulo, V; Coloni, Giorgio Furio. - In: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. - ISSN 1010-7940. - STAMPA. - 31:4(2007), pp. 714-718. [10.1016/j.ejcts.2007.01.017]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/231268
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 55
  • ???jsp.display-item.citation.isi??? 50
social impact